CLINICAL_TRIALS
research
· 2012-10-12
Clinical Trial Update: Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis [Phase 4]
Summary
A Phase 4 clinical trial update examining how vitamin A affects RAR gene expression in relapsing-remitting multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tehran University of Medical Sciences | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: UNKNOWN